SUZHOU, CHINA

CSTONE ANNOUNCED NEW DRUG APPROVAL OF CEJEMLY® (SUGEMALIMAB) IN CHINA TO POTENTIALLY RESHAPE THE LANDSCAPE OF IMMUNO-ONCOLOGY THERAPY IN LUNG CANCER

CStone Pharmaceuticals (the “Company” or “CStone“) is pleased to announce that the National Medical Products Administration (“NMPA“) of China has approved the new drug application (“NDA“) of anti-PD-L1 monoclonal antibody Cejemly® (sugemalimab) in combination with chemotherapy for treatment-naïve metastatic (stage IV) non-small cell lung cancer (“non-small cell lung caner” or…

thaipr.net

21 ธ.ค. 64

CStone Pharmaceuticals and Jiangsu Hengrui Pharmaceuticals announce strategic partnership and exclusive licensing agreement on anti-CTLA-4 monoclonal antibody CS1002 in Greater China

– CStone granted the exclusive rights to Hengrui for research, development, registration, manufacturing, and commercialization of anti-CTLA-4 mAb CS1002 in the Greater China region – CStone will retain the rights to develop and commercialize anti-CTLA-4 mAb CS1002 outside of Greater China – CStone and Hengrui will partner respective R&D and commercial expertise to accelerate the development […]

thaipr.net

22 พ.ย. 64

XJTLU Expert: EU and China keen to cooperate on climate governance

Dr Evans Fanoulis, Xi’an Jiaotong-Liverpool University Assistant Professor in International Relations, will refer to the EU’s climate change actions during his presentation on the EU’s innovation priorities at the 3rd Global Summit on Manufacturing Outsourcing in Changchun, China, 19-20 July. “China and EU have so far developed joint projects and synergies regarding climate change, pollution […]

thaipr.net

16 ก.ค. 64

With the Second-Generation transcatheter aortic valve replacement system approved for marketing, Peijia Medical leads China into the “Retrievable Era” using TAVR products

The TaurusElite® Transcatheter Aortic Valve Replacement System (hereinafter referred to as “TaurusElite®“) developed by Peijia Medical (9996.HK) is approved for marketing by the National Medical Products Administration (NMPA) in June 2021 (Reg. No. GXZZ 20213130464). This approval will accelerate the transition of China TAVR practice into retrievable era. TaurusElite® is the second-generation TAVR system developed by Peijia…

thaipr.net

28 มิ.ย. 64
1 2 3 4

Copyright © 2025 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.